Beyond CMV Prevention - a podcast by Clinical Care Options
from 2023-12-12T21:14:12.288795
::
::
In this episode, Raymund Razonable, MD, discusses cytomegalovirus (CMV) management strategies beyond primary prophylaxis in solid organ transplantation recipients including:
- CMV treatment goals
- CMV treatment and monitoring recommendations
- Role of secondary prophylaxis
- Use of CMV cell–mediated immunity (CMI) monitoring for CMV relapse risk
- Use of CMV CMI for secondary prophylaxis
- Proposed use of CMV CMI monitoring for secondary prophylaxis
- Incidence and outcomes with antiviral resistance
- Risk factors for CMV resistance
- When to suspect antiviral resistance
- Testing for antiviral resistance using genotypic assays
- Outcomes in patients with ganciclovir-resistant vs ganciclovir-susceptible virus
- Treatment recommendations for resistant/refractory CMV
- Efficacy and safety of maribavir vs investigator-assigned therapy for resistant/refractory CMV infections from the phase III SOLTICE study
- Treatment algorithm for resistant/refractory CMV
- Adjunctive, investigational, and off-label treatment options for resistant/refractory CMV
Faculty:
Raymund Razonable, MD
Professor of Medicine
Program Director, Infectious Diseases Fellowship
Vice Chair, Division of Infectious Diseases
Mayo Clinic
Rochester, Minnesota
Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.
Follow along with a downloadable slideset at:
https://bit.ly/476v2wI
Link to full program:
https://bit.ly/47lNK2K
Further episodes of CCO Infectious Disease Podcast
Further podcasts by Clinical Care Options
Website of Clinical Care Options